AzTrials
AzTrials

StrokeCITRINeSNCT06852209

Training Cognition With Neurofeedback After Stroke

A study testing Cognitive remediation therapy, Neuropsychological assessment and Real-time functional MRI neurofeedack (rt-fMRI NF) in people with Stroke and Cognitive Impairment, run by University Hospital, Bordeaux at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Post-stroke cognitive impairment (PSCI) is a common source of invisible disability. The actual techniques of cognitive remediation have been reported to have only a small effect, justifying the need to foster research in this field. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Stroke, Cognitive Impairment
What is being tested?
Cognitive remediation therapy, Neuropsychological assessment and Real-time functional MRI neurofeedack (rt-fMRI NF)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteFrance
Study dates
28 Feb 2025to 28 Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Men or women
  • Right handed
  • 18 ≤ years old < 75
  • first-ever ischemic stroke on brain MRI in the past 3 to 6 months ;
  • Persisting cognitive complaint 3 months after the ischemic stroke, proved by a MoCA score ≤ 26 (if educational level ≥ 12 years, or ≤ 25 if educational level < 12 years), and involving at least one of the following cognitive domains : executive functions, attention, and processing speed ;
  • Ischemic stroke located in the territory of the middle cerebral artery and /or basal ganglia/thalamus ;
Show all 11Show fewer
  • NIHSS ≤ 5, without aphasia or severe visual disability empeding the understanding of the instructions, the neurofeedback task achievement, and/or the neuropsychological assessment ;
  • No prestroke disability defined by a modified Rankin Scale ≤ 2 ;
  • For women of childbearing potential, use of effective contraception and negative pregnancy test.
  • Written informed consent by the patient.
  • Coverage by the French Social Insurance

Who cannot join

  • Previous cognitive impairment ;
  • History of psychiatric disorder ;
  • Current use of psychotropic medication ;
  • MRI contraindication ;
  • Pregnancy or breastfeeding ;
  • Chronic disease empeding the follow-up of the subject during the lenght of the study ;
Show all 11Show fewer
  • Non fluently-French speakers ;
  • Patient under legal protection.
  • Patient unable of giving personal consent
  • Emergency situation
  • 1st MRI incomplete, not performed or not analyzable

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • CHU de Bordeaux

    Bordeaux

    Sharmila SAGNIER, Dr, 05 56 79 55 20, sharmila.sagnier@chu-bordeaux.fr

    Recruiting

Other trials in France

About this study

Official title: Cognitive Impairment Mechanisms and Training With Real Time-functional MRI Neurofeedback After Stroke

Post-stroke cognitive impairment (PSCI) is a common source of invisible disability. The actual techniques of cognitive remediation have been reported to have only a small effect, justifying the need to foster research in this field. Real-time functional MRI neurofeedack (rt-fMRI NF) is a procedure of brain-machine interface supporting self-regulation of brain activity, with promising results in the treatment of mental disorders. The main objective of the study is to evaluate in a pilot study, the ability of stroke patients to learn to self-regulate their brain activity in a priviledged direction, using rt-fMRI NF

Read the detailed description

Stroke is a major source of cognitive impairment including slowdown of processing speed, executive functions disturbances, attention and memory loss, that can lead to invisible disability, even before the ultimate stage of dementia. The traditional techniques of cognitive remediation have been reported to have a small effect, and european scientific societies stated on the need to foster research in the field of PSCI, with the goal of preventing cognitive decline. PSCI mechanisms arising from functional MRI studies include a disconnexion of brain networks, with a loss of segregation between networks and integration within networks, centered on the frontoparietal network. Rt-fMRI NF is a psychophysiological procedure of brain-machine interface enabling to a subject to learn to self-regulate his brain activity in a desired direction, based on the brain haemodynamic response. Promising results in the treatment of mental disorders have been reported using rt-fMRI NF, but data are scarce in the field of cognitive rehabilitation after stroke. Based on the mechanisms of PSCI reported in fMRI studies, the goal of the present study is to evaluate the ability of stroke patients to learn to self-regulate a brain target using rt-fMRI NF. The brain target is defined by the difference of activation between the central executive network (CEN, or frontoparietal network) and the default mode network (DMN), known to be highly anticorrelated with the CEN in the healthy brain. The experimental procedure will include four training sessions of rt-fMRI NF (1/week), preceded by a localizer session for the identification of the target networks, and followed by a tranfer session where the subjects will be asked to try to self-regulate their brain activity but without receiving feedback. A control group will perform the four fMRI sessions but without receiving feedback. The two groups will receive cognitive remediation therapy as treatment as usual. Resting state scans and diffusion tensor imaging seqences will be performed before and after the intervention, to measure the changes in functional and structural connectivity. A neuropsychological assessment will be also performed before and after the intervention, to measure the changes in cognitive performances.

Being tested
Cognitive remediation therapy, Neuropsychological assessment, Real-time functional MRI neurofeedack (rt-fMRI NF), fMRI sessions
Keywords
Stroke, Cognition, Real time-fMRI, Neurofeedback
Medical subject headings
Stroke, Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive remediation therapyProcedure or surgery

    Cognitive remediation therapy as treatment as usual

  • Neuropsychological assessmentProcedure or surgery

    Neuropsychological assessment to measure cognitive performances

  • Real-time functional MRI neurofeedack (rt-fMRI NF)Procedure or surgery

    Real-time functional MRI neurofeedack (rt-fMRI NF) is a procedure of brain-machine interface supporting self-regulation of brain activity, with promising results in the treatment of mental disorders. The main objective of the study is to evaluate in a pilot study, the ability of stroke patients to learn to self-regulate their brain activity in a priviledged direction.

  • fMRI sessionsProcedure or surgery

    fMRI sessions but without receiving feedback

Study groups in NCT06852209
Study groupRoleWhat they receive
Experimental groupExperimentalTraining sessions of rt-fMRI NF. The experimental procedure will include four training sessions of rt-fMRI NF (1/week), preceded by a localizer session for the identification of the target networks, and followed by a tranfer session where the subjects will be asked to try to self-regulate their brain activity but without receiving feedback
Receives: Procedure: Cognitive remediation therapy; Procedure: Neuropsychological assessment; Procedure: Real-time functional MRI neurofeedack (rt-fMRI NF)
Control groupActive comparatorFour fMRI sessions but without receiving feedback
Receives: Procedure: Cognitive remediation therapy; Procedure: Neuropsychological assessment; Procedure: fMRI sessions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Differential CEN-DMN activity and imaging contrast between regulation and rest

    Change from baseline to each training session on the CEN-DMN activity during regulation compared with rest, in the experimental and control groups

    Measured: Through study training completion, an average of 4 weeks

Secondary outcomes (16)
  1. Evolution of global cognition assessed by the Montreal Cognitive Assessment (MoCA)

    Change from baseline to the end of the study on the MoCA score. The MoCA score allows the detection of mild cognitive impairment and is ranged from 0 (minimum) to 30 (maximum : no cognitive impairment).

    Measured: Through study completion, an average of 6 weeks

  2. Evolution of executive functions assessed by a composite score

    Change from baseline to the end of the study on a composite Z-score made from the averages of the Z-scores of the following tests :

    • verbal fluency : the subject is asked to cite a maximum of animals, letters starting with the letter P and V in 60 seconds) ;
    • memory span (working memory) : the subject is asked to restitute a maximum of the items of a list immediatly after hearing them) ;
    • Trail making Test (cognitive flexibility) : the subject is asked to link a set of digits in increasing order, alternating with letters, or items of different shapes or colors, the number of errors is recorded ;
    • Stroop task (inhibition capacity) : the subject is asked to name the font color of a list of words of colors which don't match their font color ;
    • Zoo testing plan (scheduling ability) : the subject is asked to follow a list of instructions for the visit of a zoo, while dealing with a list of constraints.

    Measured: through study completion, an average of 6 weeks

  3. Evolution of attentional functions assessed by the Mesulam cancellation task

    Change from baseline to the end of the study on the Mesulam cancellation task : the subject is asked to cancel a specific target among random arrays of structured and unstructured verbal and nonverbal stimuli.

    Measured: Through study completion, an average of 6weeks

  4. Evolution of processing speed assessed by the Symbol Digit Modalities Test (SDMT)

    Change from baseline to the end of the study on the SDMT : the subject is provided with a set of symbols corresponding to numbers, and he is asked to write the symbols corresponding to a specific list of numbers in 5 minutes.

    Measured: Through study completion, an average of 6 weeks

  5. Evolution of memory functions assessed by the 16-item Free and Cued Recall

    Change from baseline to the end of the study on the 16-item Free and Cued Recall : the subject is asked to recall a set of 16 words presented by 4, immediately and after an interfering task, the number of free and cued correct recalls are recorded.

    Measured: Through study completion, an average of 6 weeks

  6. Evolution of visuospatial functions assessed by the Rey figure

    Change from baseline to the end of the study on the Rey figure : the subject is asked to copy a complex figure as quickly as possible, and then, to reproduce the figure without the model.

    Measured: Through study completion, an average of 6 weeks

  7. Evolution of language functions assessed byt the 40-item neuropsychological semantic battery

    Change from baseline to the end of the study on the 40-item neuropsychological semantic battery : the subject is asked to name a set of 40 living and non living items in verbal and visual conditions, across 6 subtests of matching.

    Measured: Through study completion, an average of 6 weeks

  8. Evolution of the Central Executive Network (CEN) activity

    Change from baseline to each training session in the CEN activity recorded in the CEN mask during regulation compared with rest, in the experimental and control groups. The CEN mask is a binary mask individualized after running a pipeline for each subject, and the functional activity into this mask is extracted to assess the specific trajectory of the CEN activity.

    Measured: Through study training completion, an average of 4 weeks

  9. Evolution of the Default Mode Network (DMN) activity

    Change from baseline to each training session in the DMN activity recorded in the DMN mask during regulation compared with rest, in the experimental and control groups. The DMN mask is a binary mask individualized after running a pipeline for each subject, and the functional activity into this mask is extracted to assess the specific trajectory of DMN activity.

    Measured: Through study training completion, an average of 4 weeks

  10. Evolution of activity in the whole brain

    Change from baseline to each training session on the whole brain activity during regulation compared with rest, in the experimental and control groups

    Measured: Through study training completion, an average of 4 weeks

  11. Evolution of resting state CEN and DMN activity

    Change in correlation between resting state CEN and DMN activity before intervention compared with after intervention.

    Measured: Through study completion, an average of 6 weeks

  12. Microstructural changes assessed by Fractional Anisotropy (FA)

    Change in median FA parameters before intervention compared with after intervention

    Measured: Through study completion, an average of 6 weeks

  13. Microstructural changes assessed by Mean Diffusivity (MD)

    Change in median MD parameters (mm2/sec) before intervention compared with after intervention

    Measured: Through study completion, an average of 6 weeks

  14. Microstructural changes assessed by Axial Diffusivity (AD)

    Change in median AD parameters (mm2/sec) before intervention compared with after intervention

    Measured: Through study completion, an average of 6 weeks

  15. Microstructural changes assessed by Radial Diffusivity (RD)

    Change in median RD parameters (mm2/sec) before intervention compared with after intervention

    Measured: Through study completion, an average of 6 weeks

  16. Differential CEN-DMN activity and imaging contrast between regulation and rest, without neurofeedback

    Change from baseline to the last fMRI session (" transfert session " without neurofeedback) on the CEN-DMN activity during regulation compared with rest, in the experimental and control groups

    Measured: Through study completion, an average of 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Feb 2025
  2. Study start28 Feb 2025
  3. Primary completion28 Oct 2026 (estimated)
  4. Study completion28 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06852209
Sponsor's protocol ID
CHUBX 2023/43
Acronym
CITRINeS
Status last verified
Mar 2025
First submitted
2 Dec 2024
Last updated
2 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive remediation therapy, Neuropsychological assessment and Real-time functional MRI neurofeedack (rt-fMRI NF) in people with Stroke and Cognitive Impairment, run by University Hospital, Bordeaux at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sharmila SAGNIER, Dr (05 56 79 55 20, sharmila.sagnier@chu-bordeaux.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Differential CEN-DMN activity and imaging contrast between regulation and rest (time frame: Through study training completion, an average of 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in